Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries

• Main Authors: Marina George (Author), Jaime Pérez Martin (Author), Mohammad AbdelGhany (Author), Foteini Gkalapi (Author), Nicolas Jamet (Author), Richelle C. Kosse (Author), Yara Ruiz García (Author), Elisa Turriani (Author), Valérie Berlaimont (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The hexavalent vaccines DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib are routinely used for primary immunization of infants against diphtheria, tetanus, pertussis, hepatitis B virus, poliomyelitis, and Haemophilus influenzae type b. A recent publication showed that after primary immunization with these v...